Ivonescimab is the first therapy to achieve statistically significant positive results in a Phase III trial compared with ...

Novocure (NASDAQ: NVCR) announced today that Optune Lua® has received a CE (Conformité Européenne) Mark for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) ...

The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.

Four physicians spoke on the panel, which was held at the Basketball Hall of Fame in Springfield, to discuss advancements in ...

Veteran actor Sharmila Tagore was diagnosed with zero-stage lung cancer in 2023. Here's what the early-stage diagnosis means, how it was treated, and why early detection matters.

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

CANCER remains a critical health challenge in Malaysia. This rising trend highlights the urgent need for effective ...

Genesis Healthcare System is integrating advanced robotic bronchoscopy technology that's less invasive to better locate and ...

As per Dr. Nikhil S Ghadyalpatil, the AI system acts as a digital assistant that scans new patient data, flags urgent ...

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% to ...